Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / 2022 - Page 19

Year: 2022

Novartis and Molecular Partners reported positive topline data from Phase 2 study for ensovibep antiviral therapeutic for COVID-19
COVID-19 | FDA | Life Science History

Novartis and Molecular Partners reported positive topline data from Phase 2 study for ensovibep antiviral therapeutic for COVID-19

On Jan. 10, 2022, Novartis Molecular Partners announced that Part A of the EMPATHY clinical trial that compared…

Read More Novartis and Molecular Partners reported positive topline data from Phase 2 study for ensovibep antiviral therapeutic for COVID-19Continue

Novavax and Serum Institute filed for Emergency Use Authorization of Novavax’ COVID-19 vaccine in South Africa
Biotechnology | COVID-19 | Infectious Disease | Nanotechnology | Vaccine

Novavax and Serum Institute filed for Emergency Use Authorization of Novavax’ COVID-19 vaccine in South Africa

On Jan. 10, 2022, Novavax and Serum Institute of India announced a regulatory submission to the South African…

Read More Novavax and Serum Institute filed for Emergency Use Authorization of Novavax’ COVID-19 vaccine in South AfricaContinue

Biden-Harris administration required insurance and group health plans to cover cost of at-home COVID-19 tests
COVID-19 | Life Science History

Biden-Harris administration required insurance and group health plans to cover cost of at-home COVID-19 tests

On Jan. 10, 2022, the Biden-Harris Administration announced it was requiring insurance companies and group health plans to…

Read More Biden-Harris administration required insurance and group health plans to cover cost of at-home COVID-19 testsContinue

First successful transplant of porcine heart into adult human with end-stage heart disease
Life Science History

First successful transplant of porcine heart into adult human with end-stage heart disease

On Jan. 10, 2022, in a first-of-its-kind surgery, a 57-year-old patient with terminal heart disease received a successful…

Read More First successful transplant of porcine heart into adult human with end-stage heart diseaseContinue

DoD awarded contract to Revival Health to purchase COVID-19 Antigen OTC kits in support of POTUS’ 500 million free at-home COVID-19 rests
COVID-19 | Life Science History

DoD awarded contract to Revival Health to purchase COVID-19 Antigen OTC kits in support of POTUS’ 500 million free at-home COVID-19 rests

On Jan. 7, 2022, the Department of Defense, in coordination with the U.S. Department of Health and Human…

Read More DoD awarded contract to Revival Health to purchase COVID-19 Antigen OTC kits in support of POTUS’ 500 million free at-home COVID-19 restsContinue

DNA from air could revolutionize the way we measure animal biodiversity
Biotechnology | Diagnostics | Disease | Environmental

DNA from air could revolutionize the way we measure animal biodiversity

On Jan. 6, 2022, two new studies published in the journal Current Biology showed that environmental DNA (eDNA)…

Read More DNA from air could revolutionize the way we measure animal biodiversityContinue

Humanigen announced target enrollment in phase 2/3 ACTIV-5/BET-B trial of Lenzilumab for treatment of COVID-19 was met
COVID-19 | Life Science History

Humanigen announced target enrollment in phase 2/3 ACTIV-5/BET-B trial of Lenzilumab for treatment of COVID-19 was met

On Jan. 5, 2021, Humanigen announced that target enrollment in the Phase 2/3 ACTIV-5/BET-B study had been achieved….

Read More Humanigen announced target enrollment in phase 2/3 ACTIV-5/BET-B trial of Lenzilumab for treatment of COVID-19 was metContinue

Pfizer and BioNTech signed global collaboration agreement to develop first mRNA-based shingles vaccine
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Pfizer and BioNTech signed global collaboration agreement to develop first mRNA-based shingles vaccine

On Jan. 5, 2022, Pfizer and BioNTech announced a new research, development and commercialization collaboration to develop a…

Read More Pfizer and BioNTech signed global collaboration agreement to develop first mRNA-based shingles vaccineContinue

NRx Pharmac submited EUA Application to US FDA for ZYESAMIᆴ (aviptadil) to treat patients at risk of death from COVID-19
COVID-19 | FDA | Life Science History | NIH

NRx Pharmac submited EUA Application to US FDA for ZYESAMIᆴ (aviptadil) to treat patients at risk of death from COVID-19

On Jan 5, 2022, NRx Pharmaceuticals announced that it had submitted an application for Emergency Use Authorization (EUA)…

Read More NRx Pharmac submited EUA Application to US FDA for ZYESAMIᆴ (aviptadil) to treat patients at risk of death from COVID-19Continue

Hologic added Aptima SARS-CoV-2 assay to its Global Access Initiative in resource-limited countries
HIV | Life Science History

Hologic added Aptima SARS-CoV-2 assay to its Global Access Initiative in resource-limited countries

On Jan 5, 2022, Hologic the addition of the Aptimaᆴ SARS-CoV-2 assay to its Global Access Initiative, a…

Read More Hologic added Aptima SARS-CoV-2 assay to its Global Access Initiative in resource-limited countriesContinue

Revelar Biotherapeutics and Twist Bioscience announced RBT-0813 neutralized SARS-CoV-2 Omicron and Delta variants
Life Science History

Revelar Biotherapeutics and Twist Bioscience announced RBT-0813 neutralized SARS-CoV-2 Omicron and Delta variants

On Jan 5, 2022, Revelar Biotherapeutics and Twist Bioscience announced that RBT-0813 binded to and neutralized the Omicron…

Read More Revelar Biotherapeutics and Twist Bioscience announced RBT-0813 neutralized SARS-CoV-2 Omicron and Delta variantsContinue

Pfizer provided U.S. Government with additional 10 million treatment courses of oral therapy to help combat COVID-19
Biotechnology | COVID-19 | Infectious Disease | Therapeutics

Pfizer provided U.S. Government with additional 10 million treatment courses of oral therapy to help combat COVID-19

On Jan. 4, 2022, Pfizer announced that the U.S. government had committed to purchasing an additional 10 million…

Read More Pfizer provided U.S. Government with additional 10 million treatment courses of oral therapy to help combat COVID-19Continue

Tonix Pharma announced exclusive collaboration with Kansas State University to develop LNP-Free mRNA vaccines
Biotechnology | Infectious Disease | Nanotechnology | Vaccine

Tonix Pharma announced exclusive collaboration with Kansas State University to develop LNP-Free mRNA vaccines

On Jan. 4, 2022, Tonix Pharmaceuticals announced an exclusive option agreement and research collaboration with Kansas State University…

Read More Tonix Pharma announced exclusive collaboration with Kansas State University to develop LNP-Free mRNA vaccinesContinue

Pfizer and BioNTech received U.S. FDA EUA of COVID-19 vaccine booster for individuals 12 years of age and older
COVID-19 | FDA | Life Science History

Pfizer and BioNTech received U.S. FDA EUA of COVID-19 vaccine booster for individuals 12 years of age and older

On Jan. 3, 2022, Pfizer and BioNTech announced that the U.S. Food and Drug Administration had expanded the…

Read More Pfizer and BioNTech received U.S. FDA EUA of COVID-19 vaccine booster for individuals 12 years of age and olderContinue

Amyris and Immunitybio completed joint venture for next generation Covid-19 RNA vaccine
COVID-19 | Life Science History | Vaccine

Amyris and Immunitybio completed joint venture for next generation Covid-19 RNA vaccine

On Jan. 3, 2022, Amyris and ImmunityBio announced the completion of a previously announced joint venture agreement to…

Read More Amyris and Immunitybio completed joint venture for next generation Covid-19 RNA vaccineContinue

Lenzilumab treatment response in hospitalized COVID-19 patients correlated with C-Reactive protein levels
COVID-19 | Life Science History

Lenzilumab treatment response in hospitalized COVID-19 patients correlated with C-Reactive protein levels

On Jan. 3, 2021, Humanigen announced that a manuscript detailing the results of an analysis of CRP levels…

Read More Lenzilumab treatment response in hospitalized COVID-19 patients correlated with C-Reactive protein levelsContinue

Page navigation

Previous PagePrevious 1 … 17 18 19
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search